Operating Income: The income after operating expenses.
Insight Molecular Diagnostics Inc. (IMDX) had Operating Income of $-11.40M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.24M |
|
$-11.26M |
|
$0.08M |
|
$0.16M |
|
$11.64M |
|
|
Operating Income |
$-11.40M |
$0.14M |
|
$-11.26M |
|
$-11.26M |
|
$-11.26M |
|
$-11.26M |
|
$-11.26M |
|
$-11.26M |
|
$-11.40M |
|
$-10.74M |
|
36.75M |
|
36.75M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$20.54M |
|
$6.00M |
|
$8.90M |
|
$29.44M |
|
$10.29M |
|
$0.92M |
|
$40.46M |
|
$50.74M |
|
$-21.30M |
|
$-21.30M |
|
$-21.30M |
|
32.62M |
|
| Cash Flow Statement Financials | |
$-16.91M |
|
$-1.39M |
|
$24.13M |
|
$12.92M |
|
$18.73M |
|
$5.81M |
|
$1.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.00 |
|
-- |
|
-- |
|
-0.04 |
|
-0.04 |
|
65.69% |
|
-4770.71% |
|
-4770.71% |
|
-- |
|
-4711.30% |
|
-4711.30% |
|
$-18.30M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.40 |
|
1.24 |
|
72.30 |
|
52.87% |
|
52.87% |
|
-38.24% |
|
55.24% |
|
$-0.65 |
|
$-0.50 |
|
$-0.46 |
|